Viking Therapeutics (VKTX) Invested Capital (2015 - 2018)

Viking Therapeutics (VKTX) has 4 years of Invested Capital data on file, last reported at $1.9 million in Q1 2018.

• For the quarter ending Q1 2018, Invested Capital fell 1.95% year-over-year to $1.9 million; the trailing twelve-month figure through Dec 2018 stood at $1.9 million (down 75.24% YoY), and the FY2017 full-year result was $1.9 million, down 1.95% from the prior year.
• Invested Capital held at $1.9 million in Q1 2018, from $1.9 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $2.5 million in Q4 2015 to a low of $1.9 million in Q3 2017.
• A 4-year average of $2.0 million and a median of $2.0 million in 2016 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital dropped 21.79% in 2016 and changed 0.0% in 2017, its largest moves.
• Tracing VKTX's Invested Capital over 4 years: stood at $2.5 million in 2015, then declined by 21.79% to $2.0 million in 2016, then decreased by 1.95% to $1.9 million in 2017, then changed by 0.0% to $1.9 million in 2018.
• Business Quant data shows VKTX's Invested Capital at $1.9 million in Q1 2018, $1.9 million in Q4 2017, and $1.9 million in Q3 2017.